Sofwave Medical

Sofwave Medical EBITDA per Share

The EBITDA per Share of Sofwave Medical (SOFW.TA) as of Oct 21, 2026 is -0.07 USD. In the previous year, EBITDA per Share was -0.20 USD — a change of -63.45% (higher).

EBITDA per Share

-0.07USD

YoY

-63.45%

Last updated:

EBITDA per Share of Sofwave Medical is 2024 -0.07 USD. EBITDA per Share of Sofwave Medical was 2023 -0.20 USD. It decreases by -63.45% higher compared to the previous year.

The Sofwave Medical EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2020
-0.19 USD
Jan 1, 2021
-0.26 USD
Jan 1, 2022
-0.51 USD
Jan 1, 2023
-0.20 USD
Jan 1, 2024
-0.07 USD
The Sofwave Medical EBITDA per Share history
YEAREBITDA per ShareYoY
-0.07USD-63.45%
-0.20USD-60.63%
-0.51USD+96.72%
-0.26USD+35.42%
-0.19USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sofwave Medical Stock analysis

What does Sofwave Medical do? Sofwave Medical Ltd, based in Yokneam, Israel, develops, produces, and markets medical devices for skin rejuvenation and firming using non-invasive Synchronous Ultrasound Parallel Beam (SUPERB) technology. The company operates globally, with a subsidiary in the United States, offering solutions for facial and neck treatments that provide safe, clinically effective skin tightening without surgery. Its products are distributed through its own channels and subsidiaries. Sofwave Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sofwave Medical stock

EBITDA per Share of Sofwave Medical is -0.07 USD in 2024.

EBITDA per Share of Sofwave Medical changed from -0.20 USD to -0.07 USD, representing a -63.45% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Sofwave Medical since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Sofwave Medical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Sofwave Medical